While the tax exclusion for employer-sponsored health care was not included in the House-passed reconciliation bill, it ...

A new analysis of obesity guidelines suggests more evidence is needed to develop stronger guidelines for the transition ...

Cemiplimab improved disease-free survival in patients with high-risk cutaneous squamous cell carcinoma (CSCC) and performed ...

Outcomes were evaluated among children born between April 1980 and June 2019 by using data from 12 observational birth ...

Real-world data show no significant differences in overall survival between patients with or without cytogenetic risk factors ...

A combination of acalabrutinib and venetoclax showed better results with the addition of obinutuzumab, whereas mixed findings ...

Nonalcoholic fatty liver disease (NAFLD) was linked to elevated liver enzymes in type 2 diabetes mellitus (T2DM) in a recent ...

The findings support the clinical benefits of delandistrogene moxeparvovec in patients with Duchenne muscular dystrophy (DMD) ...

Bringing this interview with Marla Black Morgan, MD, to a close, she looks to the future of research in both myasthenia ...

The Trump administration has ended a program seeking a vaccine for HIV, the first in a series of decisions that is leaving ...

Skepticism still persists around the use of measurable residual disease (MRD) for clinical and regulatory decision-making in ...

Early results from the phase 1 SANRECO trial suggest that divesiran is safe and well tolerated, and may reduce the need for phlebotomy in patients with polycythemia vera by increasing hepcidin levels ...